Joseph Cooney,Spyros I Siakavellas,Peter L Chiodini et al.
Joseph Cooney et al.
With increasing international travel and migration, tropical and infectious diseases once largely confined to specialist institutes now present more widely. Amoebiasis is a potentially dangerous example since it may closely mimic the presen...
Optimising triage of urgent referrals for suspected IBD: results from the Birmingham IBD inception study [0.03%]
优化疑似炎症性肠病急会诊的分诊：伯明翰疑似炎症性肠病队列研究的结果分析
Peter Rimmer,Jonathan Cheesbrough,Jane Harris et al.
Peter Rimmer et al.
Objective: Diagnostic delays in inflammatory bowel disease (IBD) result in adverse outcomes. We report a bespoke diagnostic pathway to assess how best to combine clinical history and faecal calprotectin (FCP) for early di...
Liver transplant assessment for hepatocellular carcinoma: a single-centre experience [0.03%]
肝细胞癌的肝脏移植评估：单中心经验
Rosemary Elizabeth Faulkes,Sean Morris,Oliwia Bolimowska et al.
Rosemary Elizabeth Faulkes et al.
Objective: The incidence of hepatocellular carcinoma (HCC) continues to rise dramatically in the UK. Liver transplantation offers a potential cure and there is a large body of evidence demonstrating good outcomes. However...
Correction: Recent advances in the diagnosis and management of amoebiasis [0.03%]
关于“阿米巴病诊断和治疗近况”的更正及相关评论摘要
[This corrects the article DOI: 10.1136/flgastro-2023-102554.]. © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial ...
Published Erratum
Frontline gastroenterology. 2025 Apr 8;16(3):e2. DOI:10.1136/flgastro-2023-102554corr1 2025
Real-world effectiveness of upadacitinib in Crohn's disease: a UK multicentre retrospective cohort study [0.03%]
乌帕替尼治疗克罗恩病的现实世界有效性：英国多中心回顾性队列研究
Alexander Thomas Elford,Maria Bishara,Nikolas Plevris et al.
Alexander Thomas Elford et al.
Background: Upadacitinib is a Janus kinase inhibitor, which has recently been approved for treating Crohn's disease. There are limited real-world studies on the outcomes of upadacitinib in Crohn's disease. ...
Significance and structure of clinical research in the UK: an introduction for gastroenterology and hepatology nurses [0.03%]
英国临床研究的意义和结构：胃肠病和肝病护士入门指南
Billye J Olsen,Karen Kemp,Rachel Campbell et al.
Billye J Olsen et al.
This is the first of two articles from the joint British Society of Gastroenterology Nurses association and Research Committee working group. The group is dedicated to signposting and improving access to research for specialist nurses worki...
What is the clinical significance of low serum amylase? Systematic review of the conditions associated with low serum amylase [0.03%]
血清淀粉酶降低的临床意义是什么？系统性回顾相关疾病状况
Mustafa Jalal,Sebastine A Gbadegesin,Nadeem Tehami et al.
Mustafa Jalal et al.
Objective: Most studies have assessed the impact of elevated serum amylase levels in clinical practice, but only a few have investigated the significance of low serum amylase. We therefore, aimed to review the literature ...
R Mark Beattie
R Mark Beattie
Erratum: Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II) [0.03%]
他加力α治疗肝性脑病患者长期生存和医疗资源使用的现实世界证据：一项回顾性观察延长研究（IMPRESSⅡ）的错误声明公告
[This corrects the article DOI: 10.1136/flgastro-2022-102221.]. © Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permission...
Published Erratum
Frontline gastroenterology. 2023 Dec 7;15(1):e1. DOI:10.1136/flgastro-2022-102221corr1 2023
Colonoscopic cancer detection rate: a new performance measure - is it FIT for purpose? [0.03%]
colonoscopy检查的癌症检出率：一个新的性能指标，是否恰到好处？
Khalid Bashir,Iosif Beintaris,Linda Sharp et al.
Khalid Bashir et al.
Introduction: Gastrointestinal symptoms correlate poorly with cancer diagnosis. A faecal immunochemical test (FIT) result of ≥10 µg has high sensitivity and negative predictive value for colorectal cancer (CRC) detectio...